Barker RA - Search Results

1

Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.

Kilarski LL, Pearson JP, Newsway V, Majounie E, Knipe MD, Misbahuddin A, Chinnery PF, Burn DJ, Clarke CE, Marion MH, Lewthwaite AJ, Nicholl DJ, Wood NW, Morrison KE, Williams-Gray CH, Evans JR, Sawcer SJ, Barker RA, Wickremaratchi MM, Ben-Shlomo Y, Williams NM, Morris HR. Kilarski LL, et al. Among authors: barker ra. Mov Disord. 2012 Oct;27(12):1522-9. doi: 10.1002/mds.25132. Epub 2012 Sep 6. Mov Disord. 2012. PMID: 22956510 Review.

2

Repairing the brain in Parkinson's disease: where next?

Barker RA. Barker RA. Mov Disord. 2002 Mar;17(2):233-41. doi: 10.1002/mds.10091. Mov Disord. 2002. PMID: 11921107 Review. No abstract available.

3

Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism.

Foltynie T, Goldberg TE, Lewis SG, Blackwell AD, Kolachana BS, Weinberger DR, Robbins TW, Barker RA. Foltynie T, et al. Among authors: barker ra. Mov Disord. 2004 Aug;19(8):885-91. doi: 10.1002/mds.20118. Mov Disord. 2004. PMID: 15300652

4

A genome wide linkage disequilibrium screen in Parkinson's disease.

Foltynie T, Hicks A, Sawcer S, Jonasdottir A, Setakis E, Maranian M, Yeo T, Lewis S, Brayne C, Stefansson K, Compston A, Gulcher J, Barker RA. Foltynie T, et al. Among authors: barker ra. J Neurol. 2005 May;252(5):597-602. doi: 10.1007/s00415-005-0686-2. Epub 2005 Feb 23. J Neurol. 2005. PMID: 15726250

5

No alterations in alpha-synuclein gene dosage observed in sporadic Parkinson's disease.

Williams-Gray CH, Goris A, Foltynie T, Brown J, Maranian M, Walton A, Compston DA, Sawcer SJ, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. Mov Disord. 2006 May;21(5):731-2. doi: 10.1002/mds.20863. Mov Disord. 2006. PMID: 16552758 No abstract available.

6

Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.

Williams-Gray CH, Foltynie T, Lewis SJ, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. CNS Drugs. 2006;20(6):477-505. doi: 10.2165/00023210-200620060-00004. CNS Drugs. 2006. PMID: 16734499 Review.

7

Visual hallucinations predict increased benefits from rivastigmine in Parkinson's disease dementia.

Williams-Gray CH, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. Nat Clin Pract Neurol. 2007 May;3(5):250-1. doi: 10.1038/ncpneuro0471. Epub 2007 Mar 20. Nat Clin Pract Neurol. 2007. PMID: 17375057 No abstract available.

8

Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease.

Williams-Gray CH, Hampshire A, Robbins TW, Owen AM, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. J Neurosci. 2007 May 2;27(18):4832-8. doi: 10.1523/JNEUROSCI.0774-07.2007. J Neurosci. 2007. PMID: 17475791 Free PMC article.

9

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.

Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJ, Brown J, Ban M, Spillantini MG, Compston A, Burn DJ, Chinnery PF, Barker RA, Sawcer SJ. Goris A, et al. Among authors: barker ra. Ann Neurol. 2007 Aug;62(2):145-53. doi: 10.1002/ana.21192. Ann Neurol. 2007. PMID: 17683088

10

Predictors of punding in Parkinson's disease: results from a questionnaire survey.

Lawrence AJ, Blackwell AD, Barker RA, Spagnolo F, Clark L, Aitken MR, Sahakian BJ. Lawrence AJ, et al. Among authors: barker ra. Mov Disord. 2007 Dec;22(16):2339-45. doi: 10.1002/mds.21702. Mov Disord. 2007. PMID: 17914729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

626 results

Search Page